Abingdon Health Plc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A£ (N/A)
Beta N/A
Market capitalization 7.77M
Operating cash flow N/A
ESG Scores unknown

Company description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Sector: Healthcare - Industry: Diagnostics & Research

Financial data

Financial Statements

Cashflow Statement
Change To Liabilities
Total Cashflows From Investing Activities
Net Borrowings
Total Cash From Financing Activities
Change To Operating Activities
Issuance Of Stock
Net Income
Change In Cash
Effect Of Exchange Rate
Total Cash From Operating Activities
Depreciation
Change To Account Receivables
Other Cashflows From Financing Activities
Change To Netincome
Capital Expenditures

Income Statement
Research Development
Income Before Tax
Net Income
Selling General Administrative
Gross Profit
Ebit
Operating Income
Interest Expense
Income Tax Expense
Total Revenue
Cost Of Revenue
Total Other Income ExpenseNet
Net Income From Continuing Ops
Net Income Applicable To Common Shares

Balance Sheet Statement
Total Liabilities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Treasury Stock
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant, and Equipment
Total Current Assets
Net Tangible Assets
Net Receivables
Accounts Payable


Insider Transactions

Here are the insider transactions of stock shares related to Abingdon Health Plc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Yates (Christopher Henry Francis)Bought at price 0.08 per share.D2022-09-23125k
Hand (Christopher William)Bought at price 0.07 per share.D2022-09-1650k
Hand (Christopher William)Bought at price 0.08 per share.D2022-09-16300k
Hand (Christopher William)Bought at price 0.07 per share.D2022-09-1464.07k
Hand (Christopher William)Bought at price 0.07 per share.D2022-09-14500k
Yates (Christopher Henry Francis)Bought at price 0.33 per share.D2021-12-211M
Hand (Christopher William)Bought at price 0.33 per share.D2021-12-21999.6k
Hargreaves Lansdown Asset Management Ltd.D2021-11-19
Hand (Christopher William)D2021-11-19
NPIF YHTV Equity LPD2021-11-19
Thornapple LLPD2021-11-19
Touchstone Innovations Businesses LLPD2021-11-19
Yates (Christopher Henry Francis)D2021-11-19
University of BirminghamD2021-11-19
CatenaLucis LLCD2021-11-19
Yates (Christopher Henry Francis)D2021-11-17
Ross (Melanie)D2021-11-17
Hand (Christopher William)D2021-11-17
Touchstone Innovations Businesses LLPD2021-10-29
Hargreaves Lansdown Asset Management Ltd.D2021-10-29
NPIF YHTV Equity LPD2021-10-29
CatenaLucis LLCD2021-10-29
University of BirminghamD2021-10-29
Thornapple LLPD2021-10-29
Ross (Melanie)Bought at price 1.29 per share.D2021-04-065.34k
Marlow (Richard)D2020-12-15
AXA Investment ManagersD2020-12-15
Unicorn Asset Management LtdD2020-12-15
Humble Rogue Ventures LLCD2020-12-15
Jefferis (Roy)D2020-12-15
Kaden Biotech, Ltd.D2020-12-15
Lewis (Chris)D2020-12-15
Lewis (Tracie)D2020-12-15
Touchstone Innovations Businesses LLPD2020-12-15
Page (Scott Andrew)D2020-12-15
University of BirminghamD2020-12-15
Nicholas Properties UK, Ltd.D2020-12-15
Yates (Christopher Henry Francis)D2020-12-15
NPIF YHTV Equity LPD2020-12-15
Thornapple LLPD2020-12-15
Pollard (Brett D)D2020-12-15
Chelverton Asset Management LtdD2020-12-15
Hand (Phil)D2020-12-15
Cobbold (Mark)D2020-12-15
Drayson (Mark)D2020-12-15
Borrows (Jason)D2020-12-15
Hand (Nicola)D2020-12-15
Hand (Christopher William)D2020-12-15
Godstow Holdings LLCD2020-12-15
CatenaLucis LLCD2020-12-15

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Abingdon Health Plc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Abingdon Health Plc

Here is the result of two systematic investment strategies applied to Abingdon Health Plc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Abingdon Health Plc

The following chart shows the equity curve of the two systematic investment strategies applied to Abingdon Health Plc:

Abingdon Health Plc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Abingdon Health Plc

This is the result of two momentum investment strategies applied to Abingdon Health Plc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Abingdon Health Plc

The following chart shows all the entries opened by the momentum investment system on Abingdon Health Plc:

Abingdon Health Plc momentum entries
  • The first momentum investment strategy would give -9.26% of return on Abingdon Health Plc. That represents -91.5£ of latent gain with 988.5£ of employed capital.
  • The second momentum investment strategy would give -11.63% of return on Abingdon Health Plc. That represents -59.0£ of latent gain with 507.5£ of employed capital.
Performance at glance (1Q Momentum)

Performance

-9.26 %

Latent gain

-91.5 £

Invested capital

988.5 £

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

-11.63 %

Latent gain

-59.0 £

Invested capital

507.5 £

Annualized return

-72.69 %

Momentum equity curve on Abingdon Health Plc

The following chart shows the equity curve of the two momentum strategies applied to Abingdon Health Plc:

Abingdon Health Plc momentum equity

Note: the dividends potentially given by Abingdon Health Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Abingdon Health Plc

The following chart shows the employed capital evolution of the two momentum strategies on Abingdon Health Plc since the beginning:

Abingdon Health Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on Abingdon Health Plc

Buy the dip entry openings on Abingdon Health Plc

Abingdon Health Plc

The performance achieved by the robo-advisor on Abingdon Health Plc is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows Abingdon Health Plc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Abingdon Health Plc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

-0.0 %

Equity curve of the strategy applied to Abingdon Health Plc

The following chart shows the result of the investment strategy applied to Abingdon Health Plc:

Abingdon Health Plc

Note: the dividends potentially given by Abingdon Health Plc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Abingdon Health Plc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Abingdon Health Plc:

Abingdon Health Plc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Abingdon Health Plc

In this section, I will compare the three previous investment strategies applied to Abingdon Health Plc.

Equity curve comparison on Abingdon Health Plc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Abingdon Health Plc investment strategy comparison

Employed capital comparison on Abingdon Health Plc

Abingdon Health Plc investment comparison

Performance comparison on Abingdon Health Plc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0£ 0.0£ 0.0%
Momentum 1 quarter -9.26% -91.5£ 988.5£ -23.15%
Momentum 2 quarters -11.63% -59.0£ 507.5£ -72.69%
Non-directional 0% 0.0£ 0.0£ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-72.69 %

Momentum 2Q

-72.69 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Abingdon Health Plc:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Abingdon Health Plc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Abingdon Health Plc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Abingdon Health Plc
Country United Kingdom
City York
Address York Biotech Campus
Phone 44 19 0440 6050
Website www.abingdonhealth.com
FullTime employees 123
Industry Diagnostics & Research
Sector Healthcare
Exchange XLON
Ticker ABDX.XLON
Market www.londonstockexchange.com

Abingdon Health Plc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown